# ğŸ§ª Experiment & Research Guidelines

## 0) Purpose
**Not "plausible backtests" but reproducible decision-making (deploy/shelve/discard).**

Experiment = *(hypothesis â†’ implementation â†’ validation â†’ falsification â†’ decision)*

---

## 1) Hard Rules (ì ˆëŒ€ ê·œì¹™)

### 1.1 No Look-Ahead Bias
* **Any t+1 information in t-time decision = failure**
* Common leaks: `center=True`, future ffill/bfill, label/feature timing mismatch, survivorship bias

### 1.2 Data Snooping Prevention
* **1 experiment = 1 hypothesis + 1 change**
* More tuning = overfitting, not discovery
* Changing rules after seeing results = new experiment

### 1.3 One Variable at a Time (ì‹¤í—˜ ë…ë¦½ì„±)
**CRITICAL: í•œ ì‹¤í—˜ë‹¹ í•˜ë‚˜ì˜ íš¨ê³¼ë§Œ ì¸¡ì • ê°€ëŠ¥í•˜ë„ë¡ ì„¤ê³„**

**ğŸ¯ ì‹¤í—˜ ìˆœì„œ (MANDATORY):**
1. **Phase 1: Individual Effects (ê°œë³„ íš¨ê³¼)**
   - ê° ë³€ìˆ˜ë¥¼ **í•˜ë‚˜ì”©** ë…ë¦½ì ìœ¼ë¡œ í…ŒìŠ¤íŠ¸
   - ë‹¤ë¥¸ ëª¨ë“  ì¡°ê±´ ê³ ì •
   - ê° ë³€ìˆ˜ì˜ ìˆœìˆ˜ íš¨ê³¼ ì¸¡ì •
   
2. **Phase 2: Joint Effects (ê²°í•© íš¨ê³¼)**
   - Phase 1 ì™„ë£Œ í›„ì—ë§Œ í—ˆìš©
   - ê°œë³„ íš¨ê³¼ê°€ í™•ì¸ëœ ë³€ìˆ˜ë“¤ì˜ ì¡°í•©
   - ìƒí˜¸ì‘ìš©(interaction) íš¨ê³¼ ë¶„ì„

**ìˆœì„œ ìœ„ë°˜ = ì‹¤í—˜ ë¬´íš¨**

---

* âŒ **ë‚˜ìœ ì˜ˆ (ì—¬ëŸ¬ ë³€ìˆ˜ ë™ì‹œ ë³€ê²½)**:
  - "IV í•„í„° 10% â†’ 15% + TTE í•„í„° 3d â†’ 5d + ë ˆì§ Bull â†’ Bear ë™ì‹œ ë³€ê²½"
  - "ìˆ˜ìˆ˜ë£Œ ëª¨ë¸ ë³€ê²½ + ì§„ì… ë¡œì§ ë³€ê²½ + ì²­ì‚° ë¡œì§ ë³€ê²½"
  - â†’ **ë¬´ì—‡ì´ ì„±ê³¼ë¥¼ ë°”ê¿¨ëŠ”ì§€ ì•Œ ìˆ˜ ì—†ìŒ**
  - â†’ **Phase 1 ì—†ì´ ë°”ë¡œ Phase 2 ì‹œë„ = ê¸ˆì§€**

* âœ… **ì¢‹ì€ ì˜ˆ (Phase 1 â†’ Phase 2 ìˆœì„œ)**:
  
  **Phase 1 (ê°œë³„ íš¨ê³¼):**
  - **Exp A**: IV í•„í„° 10% â†’ 15% (ë‹¤ë¥¸ ëª¨ë“  ê²ƒ ê³ ì •)
  - **Exp B**: TTE í•„í„° 3d â†’ 5d (ë² ì´ìŠ¤ë¼ì¸ì—ì„œ, IV=10% ê³ ì •)
  - **Exp C**: ë ˆì§ Bull â†’ Bear (ë² ì´ìŠ¤ë¼ì¸ì—ì„œ, IV=10%, TTE=3d ê³ ì •)
  
  **Phase 1 ê²°ê³¼:**
  - Exp A: Sharpe +0.3 âœ… (ì±„íƒ)
  - Exp B: Sharpe +0.1 âœ… (ì±„íƒ)
  - Exp C: Sharpe -0.2 âŒ (ê¸°ê°)
  
  **Phase 2 (ê²°í•© íš¨ê³¼, Phase 1 ì™„ë£Œ í›„):**
  - **Exp D**: IV=15% + TTE=5d (A, B ê²°í•©)
  - **ë¶„ì„**: Sharpe(D) vs [Sharpe(A) + Sharpe(B)]
    - ê°™ìœ¼ë©´: ë…ë¦½ íš¨ê³¼ (interaction ì—†ìŒ)
    - ë‹¤ë¥´ë©´: ìƒí˜¸ì‘ìš© íš¨ê³¼ (synergy or interference)

* âœ… **Grid Search (Phase 1 ëŒ€ì²´ ê°€ëŠ¥)**:
  - ëª¨ë“  íŒŒë¼ë¯¸í„° ì¡°í•© í…ŒìŠ¤íŠ¸ (NÃ—M ì‹¤í—˜)
  - **ë°˜ë“œì‹œ ê° ì°¨ì›ë³„ marginal effect ë¶„ì„ í¬í•¨**
  - **ìƒí˜¸ì‘ìš©(interaction) ìˆìœ¼ë©´ ëª…ì‹œì ìœ¼ë¡œ ë³´ê³ **
  - Grid Search ì™„ë£Œ = Phase 1 ì™„ë£Œë¡œ ê°„ì£¼

**ì‹¤í—˜ ì„¤ê³„ ì‹œ ì²´í¬ë¦¬ìŠ¤íŠ¸:**
1. âš ï¸ ì´ë²ˆ ì‹¤í—˜ì—ì„œ **ë‹¨ í•˜ë‚˜ì˜ ë³€ìˆ˜**ë§Œ ë°”ë€Œì—ˆëŠ”ê°€?
2. âš ï¸ ë‹¤ë¥¸ ëª¨ë“  ì¡°ê±´ì€ **ì´ì „ ì‹¤í—˜ê³¼ ë™ì¼**í•œê°€?
3. âš ï¸ ë² ì´ìŠ¤ë¼ì¸(ë¹„êµ ëŒ€ìƒ)ì´ **ëª…í™•**í•œê°€?
4. âš ï¸ ê²°ê³¼ ì°¨ì´ë¥¼ **ì´ ë³€ìˆ˜ í•˜ë‚˜ë¡œ ì„¤ëª…** ê°€ëŠ¥í•œê°€?

**ìœ„ë°˜ ì‹œ ì¡°ì¹˜:**
- ì‹¤í—˜ ê²°ê³¼ ë¬´íš¨ ì²˜ë¦¬
- ë³€ìˆ˜ ë¶„ë¦¬í•˜ì—¬ ì¬ì„¤ê³„
- ê° ë³€ìˆ˜ë‹¹ ë…ë¦½ ì‹¤í—˜ ìˆ˜í–‰

### 1.4 Reproducibility Obligation
* Must include: code version, data version, config, seed, command, output paths
* "Somehow it will reproduce" is prohibited

---

## 2) Agent Behavior (Anti-Passive Mode)

### ğŸš€ AUTONOMOUS EXECUTION (ì ˆëŒ€ ì›ì¹™)

**NEVER ask "Should I run this?" or "Shall I execute?"**

* **When user says "experiment", "test", "try", "analyze":**
  - âœ… Design experiment â†’ Write code â†’ **EXECUTE IMMEDIATELY** â†’ Report results
  - âŒ Design experiment â†’ Write code â†’ Ask permission â†’ Wait
  
* **Default behavior:**
  - Run baseline (2+ variants)
  - Run main experiment (3-5 parameter settings)
  - Run falsification tests (shift/placebo/permutation)
  - **ALL WITHOUT ASKING**

* **Only ask when:**
  - Destructive operation (delete data, overwrite important files)
  - Financial cost involved (API calls with billing)
  - Computation takes >30 minutes (then inform + run in background)

### ğŸ”„ Iterative Experimentation

* **Don't stop at first result**
  - Run 3-5 parameter variations automatically
  - Test edge cases (min/max values)
  - Compare multiple baselines
  - Always run falsification tests

* **When stuck >10min**: Present "3 causes + 3 experiments" and **EXECUTE ALL 3**
* **When results good**: **AUTOMATICALLY** perform breaking experiments (stress/placebo/permutation)
* **Default**: (1) Run 2+ baselines â†’ (2) Run main â†’ (3) Run falsification â†’ (4) Report all together

---

## 3) Experiment Workflow

### Step A. Experiment Card (Brief but Mandatory)

**ë°˜ë“œì‹œ ëª…ì‹œ:**
- **Hypothesis**: "X improves Y" (êµ¬ì²´ì ìœ¼ë¡œ)
- **Isolated Variable**: ì´ë²ˆ ì‹¤í—˜ì—ì„œ **ìœ ì¼í•˜ê²Œ** ë°”ë€ŒëŠ” ë³€ìˆ˜
- **Control Group (Baseline)**: ë¹„êµ ëŒ€ìƒ (ì´ì „ ìµœì  ì„¤ì • or í‘œì¤€ ì„¤ì •)
- **Expected Signal**: ì–´ë–¤ ì§€í‘œê°€ ì–¼ë§ˆë‚˜ ê°œì„ ë  ê²ƒì¸ê°€?
- **Failure Condition**: ì–´ë–¤ ê²°ê³¼ê°€ ë‚˜ì˜¤ë©´ ê¸°ê°í•˜ëŠ”ê°€?

**ì˜ˆì‹œ:**
```
Hypothesis: IV ê³¼ëŒ€í‰ê°€ í•„í„°ë¥¼ 15%ë¡œ ì˜¬ë¦¬ë©´ ê±°ì§“ ì‹ í˜¸ ê°ì†Œ â†’ Sharpe ê°œì„ 
Isolated Variable: IV filter threshold (10% â†’ 15%)
Control Group: í˜„ì¬ ìš´ì˜ì¤‘ì¸ 10% ì„¤ì • (ëª¨ë“  ë‹¤ë¥¸ íŒŒë¼ë¯¸í„° ë™ì¼)
Expected Signal: Sharpe +0.3 ì´ìƒ, ê±°ë˜ ë¹ˆë„ -20% ì´ë‚´
Failure Condition: Sharpe ë³€í™” ì—†ê±°ë‚˜, ê±°ë˜ ë¹ˆë„ -50% ì´ìƒ
```

**ê¸ˆì§€ ì‚¬í•­:**
- âŒ "ì—¬ëŸ¬ ê°€ì§€ ê°œì„  ì‚¬í•­ í…ŒìŠ¤íŠ¸"
- âŒ "ì „ë°˜ì ì¸ ì„±ëŠ¥ í–¥ìƒ"
- âŒ "íŒŒë¼ë¯¸í„° íŠœë‹"
â†’ **ë³€ìˆ˜ê°€ 2ê°œ ì´ìƒì´ë©´ ì‹¤í—˜ì„ ë¶„ë¦¬í•˜ë¼**

### Step B. Fix Data/Universe
- Fix: period/costs/slippage/fill/leverage/rebalancing
- Prevent: survivorship, corporate actions, timezone issues

### Step C. Baseline (â‰¥2) + Ablation (â‰¥1)

**ëª©ì : ì„±ê³¼ê°€ ì¶”ê°€ëœ ë³€ìˆ˜ ë•Œë¬¸ì¸ì§€ ì¦ëª…**

* **Baseline í•„ìˆ˜ êµ¬ì„±**:
  1. **Control (ì´ì „ ìµœì  ì„¤ì •)**: ì´ë²ˆ ì‹¤í—˜ì˜ ìœ ì¼í•œ ë³€ìˆ˜ë§Œ ì´ì „ ê°’ìœ¼ë¡œ
  2. **Simple Benchmark**: ë‹¨ìˆœ ì „ëµ (buy-and-hold, moving average crossover, random)
  3. **Do Nothing**: ì•„ë¬´ê²ƒë„ ì•ˆ í•˜ëŠ” ê²½ìš° (ê±°ë˜ ë¹„ìš© zero baseline)

* **Ablation (ì œê±° ì‹¤í—˜)**:
  - ìƒˆë¡œ ì¶”ê°€í•œ ë³€ìˆ˜ë¥¼ **ì™„ì „íˆ ì œê±°**í•œ ë²„ì „
  - "ì´ ë³€ìˆ˜ê°€ ì—†ìœ¼ë©´ ì–´ë–»ê²Œ ë˜ëŠ”ê°€?"
  - ì˜ˆ: IV í•„í„° ì¶”ê°€ ì‹¤í—˜ â†’ IV í•„í„° ì™„ì „ ì œê±° ë²„ì „ë„ í…ŒìŠ¤íŠ¸

**ì‹¤í—˜ êµ¬ì¡° ì˜ˆì‹œ:**
```
Control:      IV filter = 10%, TTE = 3d, Regime = Bull  [ê¸°ì¡´ ì„¤ì •]
Experiment:   IV filter = 15%, TTE = 3d, Regime = Bull  [ë‹¨ í•˜ë‚˜ë§Œ ë³€ê²½]
Ablation:     No IV filter,    TTE = 3d, Regime = Bull  [ë³€ìˆ˜ ì™„ì „ ì œê±°]
Simple:       Buy when price > SMA(20)                   [ë‹¨ìˆœ ë²¤ì¹˜ë§ˆí¬]
```

**ë³´ê³  ì‹œ í•„ìˆ˜:**
- Control vs Experiment: ìˆœìˆ˜ ë³€ìˆ˜ íš¨ê³¼
- Experiment vs Ablation: ë³€ìˆ˜ ì¡´ì¬ ê°€ì¹˜
- Experiment vs Simple: ë³µì¡ë„ ëŒ€ë¹„ ê°œì„ 

### Step D. Validation: Walk-forward + Purge/Embargo
- Fixed time split (trainâ†’test)
- Consider purged k-fold
- "Survives by sub-period" > "works full period"

### Step E. Robustness Battery
- Cost sensitivity: 0.5Ã—, 1Ã—, 2Ã— fees/slippage
- Fill sensitivity: mid, bid/ask, adverse
- Parameter stability: nearby values
- Resampling: monthly/quarterly bootstrap
- Placebo: signal shift, label randomization

### Step F. Operational Checklist
- Max DD, DD duration
- Tail: worst 1% day/week, CVaR/ES
- Position sizing/margin risk
- Operational complexity vs profit

---

## 4) Complexity Management
**Complexity = cost. Deduct from performance.**

- Similar performance â†’ choose simpler
- Slightly better + much complex â†’ shelve/reject
- "Simple" = structure that hits core, not just fewer rules

---

## 5) Standard Deliverables (Always Leave)

**ëª¨ë“  ì‹¤í—˜ ì¢…ë£Œ ì‹œ ë°˜ë“œì‹œ í¬í•¨:**

### 5.1 Experiment Summary Table
```
Variant         | Sharpe | Max DD | Total Trades | Win Rate | Variable Changed
----------------|--------|--------|--------------|----------|------------------
Control (10%)   |  1.85  | -12.3% |     127      |   58.3%  | [baseline]
Experiment(15%) |  2.12  | -10.1% |      98      |   61.2%  | IV filter: 10â†’15%
Ablation (none) |  1.42  | -18.7% |     203      |   52.1%  | IV filter removed
Simple (SMA)    |  0.87  | -25.3% |      45      |   51.1%  | [benchmark]
```

### 5.2 Isolated Effect Analysis
**"ì´ ë³€ìˆ˜ í•˜ë‚˜ê°€ ë¯¸ì¹œ ì˜í–¥"ì„ ëª…í™•íˆ:**
```
Variable: IV filter threshold (10% â†’ 15%)
Effect:
  - Sharpe: +0.27 (1.85 â†’ 2.12, +14.6%)
  - MaxDD: +2.2% (ê°œì„ )
  - Trades: -29 (-22.8%, ì‹ í˜¸ í’ˆì§ˆ â†‘)
  - Win Rate: +2.9%

Conclusion: IV í•„í„° ê°•í™”ê°€ ê±°ì§“ ì‹ í˜¸ ì œê±°ì— íš¨ê³¼ì 
```

### 5.3 Decision
- **Deploy**: ì¦‰ì‹œ ìš´ì˜ ë°˜ì˜
- **Shelve**: ìœ ë³´ (ë‹¤ë¥¸ ì¡°ê±´ì—ì„œ ì¬ê²€ì¦ í•„ìš”)
- **Discard**: ê¸°ê° (íš¨ê³¼ ì—†ìŒ or ë¶€ì‘ìš© í¼)

### 5.4 Evidence
- 3 key metrics + sub-period breakdown
- ìµœì†Œ 2ê°œ ì´ìƒ ê¸°ê°„ì—ì„œ ì¼ê´€ì„± í™•ì¸

### 5.5 Risks
- Worst period/tail/failure modes
- ì–´ë–¤ ì‹œì¥ ì¡°ê±´ì—ì„œ ì‹¤íŒ¨í•˜ëŠ”ê°€

### 5.6 Leak/Bug Check
- Placebo/shift/random label ê²°ê³¼
- í†µê³„ì  ìœ ì˜ì„± ê²€ì¦ (p-value, permutation test)

### 5.7 Next Action
**ë‹¨ì¼ ë³€ìˆ˜ ì‹¤í—˜ ì²´ì¸:**
```
Completed: IV filter optimization (10% â†’ 15%) âœ…
Next:
  1. TTE filter (3d â†’ 5d, IV=15% ê³ ì •)
  2. Regime filter (Bull only â†’ Bull+Sideways, IV=15%, TTE=ìµœì ê°’ ê³ ì •)
  3. Position sizing (3% â†’ 5% NAV, ëª¨ë“  íŒŒë¼ë¯¸í„° ìµœì ê°’ ê³ ì •)
```

**ì ˆëŒ€ ê¸ˆì§€:**
- âŒ "ë‹¤ìŒ: ì—¬ëŸ¬ íŒŒë¼ë¯¸í„° ë™ì‹œ ìµœì í™”"
- âŒ "ë‹¤ìŒ: ì „ë°˜ì ì¸ ì„±ëŠ¥ ê°œì„ "
â†’ **í•­ìƒ ë‹¤ìŒ ì‹¤í—˜ë„ ë‹¨ì¼ ë³€ìˆ˜**

---

## 6) Proactive Experimentation

**When experimenting:**
- Don't stop after 1-2 trials
- Explore multiple parameter ranges
- Test edge cases systematically
- Report comprehensively with all findings
- Suggest next experiments based on results

